Home Newsfeeds Morgan Stanley Downgrades Five9 to Equal-Weight

Morgan Stanley Downgrades Five9 to Equal-Weight

Morgan Stanley analyst Meta Marshall downgrades Five9 (NASDAQ:FIVN) from Overweight to Equal-Weight.

byBenzinga Newsdesk

October 10, 2022

1 minute read

Morgan Stanley analyst Meta Marshall downgrades Five9 (NASDAQ:FIVN) from Overweight to Equal-Weight.

Forian Q2 Revenue Grows 44% YoY, Here Are The Details

By Vuk Zdinjak

August 12, 9:12 AM

Forian Inc. (NASDAQ: FORA) released results for the quarter ended June 30, 2022. Q2 2022 Financial Highlights

FORA

Burcon NutraScience Q1 EPS $(0.04) Down From $(0.02) YoY

By Bill Haddad

August 15, 4:24 PM

Burcon NutraScience (NASDAQ:BRCN) reported quarterly losses of $(0.04) per share. This is a 100 percent decrease over losses of $(0.02) per share from the same period last year.

BRCN

VirnetX Declares Special Cash Dividend Of $1.00 Per Share; The Dividend Will Be Paid On Or About April 17, 2023 To Shareholders Of Record On April 10, 2023

By Happy Mohamed

March 30, 8:37 AM

Commits to Further Shareholder Distributions of Significant Portion of Any Net Proceeds from Ongoing Litigation Against Apple Inc. Enters into Cooperation Agreement with Bradley L. Radoff and Michael

VHC

Sigilon Therapeutics Q2 EPS $(0.44) Up From $(0.65) YoY, Sales $2.88M Up From $2.70M YoY

By Michael Horton

August 4, 6:30 PM

Sigilon Therapeutics (NASDAQ:SGTX) reported quarterly losses of $(0.44) per share. This is a 32.31 percent increase over losses of $(0.65) per share from the same period last year. The company reported $2.88 million in

SGTX

Morgan Stanley Downgrades Five9 to Equal-Weight

Related Posts

Forian Q2 Revenue Grows 44% YoY, Here Are The Details

Burcon NutraScience Q1 EPS $(0.04) Down From $(0.02) YoY

VirnetX Declares Special Cash Dividend Of $1.00 Per Share; The Dividend Will Be Paid On Or About April 17, 2023 To Shareholders Of Record On April 10, 2023

Sigilon Therapeutics Q2 EPS $(0.44) Up From $(0.65) YoY, Sales $2.88M Up From $2.70M YoY